Detalhe da pesquisa
1.
Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses.
Haematologica
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385273
2.
Quality of life, psychological distress, and prognostic perceptions in patients with multiple myeloma.
Cancer
; 128(10): 1996-2004, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167125
3.
The role of high-dose melphalan with autologous stem-cell transplant in multiple myeloma: is it time for a paradigm shift?
Br J Haematol
; 191(5): 692-703, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32501533
4.
Pomalidomide in lenalidomide-refractory multiple myeloma: Far from futile.
Br J Haematol
; 188(4): 483-485, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566715
5.
Mezigdomide-A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma.
Cancers (Basel)
; 16(6)2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38539501
6.
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.
Blood
; 117(2): 542-52, 2011 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20956803
7.
Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia.
Haematologica
; 98(8): 1259-63, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716541
8.
Upfront or Deferred Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Triplet and Quadruplet Induction and Minimal Residual Disease/Risk-Adapted Therapy.
Cancers (Basel)
; 15(24)2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38136255
9.
Selinexor: Targeting a novel pathway in multiple myeloma.
EJHaem
; 4(3): 792-810, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37601856
10.
Characterizing dry mass and volume changes in human multiple myeloma cells upon treatment with proteotoxic and genotoxic drugs.
Clin Exp Med
; 23(7): 3821-3832, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421589
11.
A safety review of recently approved and emerging drugs for patients with relapsed or refractory multiple myeloma.
Expert Opin Drug Saf
; 22(11): 1049-1071, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906232
12.
The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma.
Semin Oncol
; 49(1): 19-26, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35105451
13.
Quality of life, psychological distress, and prognostic perceptions in caregivers of patients with multiple myeloma.
Blood Adv
; 6(17): 4967-4974, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35848842
14.
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
Lancet Haematol
; 9(5): e340-e349, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344689
15.
Selinexor for the treatment of patients with previously treated multiple myeloma.
Expert Rev Hematol
; 14(8): 697-706, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985401
16.
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.
Blood Adv
; 5(3): 861-871, 2021 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33560397
17.
Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia.
J Clin Med
; 4(4): 665-95, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25932335
18.
IVIG for thymoma-associated pseudo-obstruction: report of successful treatment.
Eur Neurol
; 58(2): 116-7, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17570918